Abstract:Metabolic reprogramming plays a critical role in hepatocarcinogenesis. However, the mechanisms regulating metabolic reprogramming in primary liver cancer (PLC) are unknown. Differentially expressed miRNAs between PLC and normal tissues were identified using bioinformatic analysis. RT-qPCR was used to determine miR-10b-5p and SCL38A2 expression levels. IHC, WB, and TUNEL assays were used to assess the proliferation and apoptosis of the tissues. The proliferation, migration, invasion, and apoptosis of PLC cells were determined using the CCK-8 assay, Transwell assay, and flow cytometry. The interaction between miR-10b-5p and SLC38A2 was determined using dual-luciferase reporter assay. A PLC xenograft model in BALB/c nude mice was established, and tumorigenicity and SLC38A2 expression were estimated. Finally, liquid chromatography – mass spectrometry (LC-MS) untargeted metabolomics was used to analyze the metabolic profiles of xenograft PLC tissues in nude mice. miR-10b-5p was a key molecule in the regulation of PLC. Compared with para-carcinoma tissues, miR-10b-5p expression was increased in tumor tissues. miR-10b-5p facilitated proliferation, migration, and invasion of PLC cells. Mechanistically, miR-10b-5p targeted SLC38A2 to promote PLC tumor growth. Additionally, miR-10b-5p altered the metabolic features of PLC in vivo . Overexpression of miR-10b-5p resulted in remarkably higher amounts of lumichrome, folic acid, octanoylcarnitine, and Beta-Nicotinamide adenine dinucleotide, but lower levels of 2-methylpropanal, glycyl-leucine, and 2-hydroxycaproic acid. miR-10b-5p facilitates the metabolic reprogramming of PLC by targeting SLC38A2, which ultimately boosts the proliferation, migration, and invasion of PLC cells. Therefore, miR-10b-5p and SLC38A2 are potential targets for PLC diagnosis and treatment.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of miR - 10b - 5p in liver cancer (PLC) and its mechanism. Specifically, through bioinformatics analysis, the researchers found that miR - 10b - 5p was significantly highly expressed in liver cancer tissues, and further verified the role of miR - 10b - 5p in promoting the proliferation, migration and invasion of liver cancer cells. In addition, the study also revealed the mechanism by which miR - 10b - 5p regulates the metabolic reprogramming of liver cancer cells by targeting SLC38A2. ### Main research contents and conclusions: 1. **High expression of miR - 10b - 5p in liver cancer tissues**: - Through bioinformatics analysis of the TCGA database, it was found that miR - 10b - 5p was significantly highly expressed in liver cancer tissues. - Clinical sample detection also confirmed this result. The expression of miR - 10b - 5p in liver cancer tissues was significantly higher than that in adjacent normal tissues. 2. **Effect of miR - 10b - 5p on the biological characteristics of liver cancer cells**: - In vitro experiments showed that the over - expression of miR - 10b - 5p promoted the proliferation, migration and invasion of liver cancer cells, while the knockdown of miR - 10b - 5p inhibited these processes. - Further experiments showed that the over - expression of miR - 10b - 5p inhibited cell apoptosis, while the knockdown of miR - 10b - 5p increased the cell apoptosis rate. 3. **miR - 10b - 5p regulates liver cancer cell metabolism by targeting SLC38A2**: - The potential target gene SLC38A2 of miR - 10b - 5p was screened out by prediction tools (TargetScan, miRDB, Diana mirror, miRanda). - The dual - luciferase reporter gene experiment verified the direct binding between miR - 10b - 5p and SLC38A2. - The experimental results showed that the over - expression of miR - 10b - 5p inhibited the expression of SLC38A2, and the over - expression of SLC38A2 reversed the promoting effect of miR - 10b - 5p on the proliferation, migration and invasion of liver cancer cells. 4. **miR - 10b - 5p promotes liver cancer tumor growth in vivo**: - A nude mouse liver cancer xenograft model was constructed. The results showed that the over - expression of miR - 10b - 5p promoted tumor growth, manifested as an increase in tumor volume and weight. - Immunohistochemistry and Western Blot analysis of tumor tissues further confirmed that the over - expression of miR - 10b - 5p inhibited the expression of SLC38A2, promoted cell proliferation and inhibited cell apoptosis. 5. **miR - 10b - 5p regulates the metabolic characteristics of liver cancer**: - Through non - targeted metabolomics analysis by liquid chromatography - mass spectrometry (LC - MS), it was found that the over - expression of miR - 10b - 5p changed the metabolic characteristics of liver cancer tissues, specifically manifested as the up - regulation of some metabolites (such as lumichrome, folic acid, octanoylcarnitine, β - nicotinamide adenine dinucleotide) and the down - regulation of some metabolites (such as 2 - methylpropanal, glycylleucine, 2 - hydroxyhexanoic acid). - Functional prediction showed that these metabolites were mainly enriched in steroid biosynthesis, one - carbon pool mediated by folic acid and aminoacyl - tRNA biosynthesis pathways. ### Conclusion: This study shows that miR - 10b - 5p regulates the metabolic reprogramming of liver cancer cells by targeting SLC38A2, thereby promoting the proliferation, migration and invasion of liver cancer cells. Therefore, miR - 10b - 5p and SLC38A2 may be potential targets for the diagnosis and treatment of liver cancer.

miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2